Changes in membrane cholesterol affect caveolin-1 localization and ICC-pacing in mouse jejunum

E E Daniel1, Gregory Bodie, Marco Mannarino

  • 1Department of Pharmacology, University of Alberta, Rm. 9-10, Medical Sciences Bldg., Edmonton, Alberta T6G 2H7, Canada. edaniel@ualberta.ca

Insights

Disrupting caveolae in mouse intestines with cholesterol modifiers (CD/WSC) altered pacing by interstitial cells of Cajal (ICC-MP). These changes suggest caveolae signaling plays a role in gut pacing.

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Physiology

Background:

  • Intestinal pacing relies on interstitial cells of Cajal in the myenteric plexus (ICC-MP).
  • Caveolae, plasma membrane invaginations rich in caveolins, act as signaling hubs.
  • Caveolins modulate signaling protein activity within caveolae.

Purpose of the Study:

  • To investigate the role of caveolae and caveolins in ICC-MP pacing.
  • To determine if caveolae disruption affects intestinal smooth muscle contractions.
  • To assess the specificity of caveolae modulation on cholinergic responses.

Main Methods:

  • Treatment of intestinal segments with methyl beta-clodextrin (CD) to deplete cholesterol and water-soluble cholesterol (WSC) to load cholesterol.
  • Measurement of pacing frequencies and paced contractions.
  • Assessment of responses to carbamoyl choline and cholinergic nerve stimulation.
  • Immunochemical and ultrastructural analysis of caveolin 1 and caveolae.

Main Results:

  • Both CD and WSC treatments reduced pacing frequencies, with effects reversed by the other agent.
  • Paced contractions were inhibited, but reversal was incomplete.
  • CD depleted caveolin 1 and caveolae; WSC altered caveolin 1 distribution but not caveolae number.
  • Neither treatment affected responses to exogenous or nerve-stimulated acetylcholine.

Conclusions:

  • Caveolae signaling in ICC-MP is implicated in intestinal pacing.
  • Caveolae modulation does not influence cholinergic neurotransmission in the intestine.